Zymergen Inc. (ZY): Price and Financial Metrics


Zymergen Inc. (ZY): $2.80

-0.28 (-9.09%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ZY to Watchlist
Sign Up

Industry: Chemicals


Ranked

of

in industry

ZY POWR Grades

  • Growth is the dimension where ZY ranks best; there it ranks ahead of 79.15% of US stocks.
  • The strongest trend for ZY is in Growth, which has been heading up over the past 177 days.
  • ZY's current lowest rank is in the Quality metric (where it is better than 2.71% of US stocks).

ZY Stock Summary

  • ZY's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.74 -- higher than only 5.48% of US-listed equities with positive expected earnings growth.
  • ZYMERGEN INC's stock had its IPO on April 22, 2021, making it an older stock than just 3.63% of US equities in our set.
  • ZYMERGEN INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 38.39%, greater than the shareholder yield of 95.25% of stocks in our set.
  • If you're looking for stocks that are quantitatively similar to ZYMERGEN INC, a group of peers worth examining would be SMSI, SPRO, ALBO, INM, and OPNT.
  • ZY's SEC filings can be seen here. And to visit ZYMERGEN INC's official web site, go to www.zymergen.com.

ZY Valuation Summary

  • ZY's price/earnings ratio is -0.8; this is 107.37% lower than that of the median Basic Materials stock.
  • ZY's price/sales ratio has moved down 250.9 over the prior 17 months.

Below are key valuation metrics over time for ZY.

Stock Date P/S P/B P/E EV/EBIT
ZY 2022-09-19 19.5 1.2 -0.8 -0.7
ZY 2022-09-16 19.0 1.2 -0.8 -0.7
ZY 2022-09-15 19.8 1.2 -0.8 -0.7
ZY 2022-09-14 19.7 1.2 -0.8 -0.7
ZY 2022-09-13 19.0 1.2 -0.8 -0.7
ZY 2022-09-12 20.2 1.2 -0.8 -0.7

ZY Price Target

For more insight on analysts targets of ZY, see our ZY price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $17.60 Average Broker Recommendation 2.21 (Moderate Sell)

ZY Stock Price Chart Interactive Chart >

Price chart for ZY

ZY Price/Volume Stats

Current price $2.80 52-week high $14.43
Prev. close $3.08 52-week low $1.10
Day low $2.79 Volume 589,100
Day high $3.00 Avg. volume 1,256,658
50-day MA $2.60 Dividend yield N/A
200-day MA $3.07 Market Cap 292.19M

Zymergen Inc. (ZY) Company Bio


Zymergen Inc. designs, engineers, and optimizes microbes for industrial applications in United States, Asia, and Europe. The company has a platform that treats the genome as a search space, to identify genetic changes that improve the economics for its customers' bio-based products for a range of industries, including chemicals and materials, agriculture, and pharmaceuticals. Zymergen's platform is used to discover novel molecules used to enable unique material properties. The company was incorporated in 2013 and is based in Emeryville, California.


ZY Latest News Stream


Event/Time News Detail
Loading, please wait...

ZY Latest Social Stream


Loading social stream, please wait...

View Full ZY Social Stream

Latest ZY News From Around the Web

Below are the latest news stories about ZYMERGEN INC that investors may wish to consider to help them evaluate ZY as an investment opportunity.

Zymergen's problems were evident to board shortly after IPO, SEC filings show

The filings come in advance of a merger with a rival for $300 million — a small fraction of the billions Zymergen once hoped to generate.

Yahoo | September 6, 2022

Last of Zymergen's 3 founders to leave as synbio company preps for merger with 80 more layoffs

Chief Scientific Officer Zach Serber, former operations chief Jed Dean and former CEO Josh Hoffman took Zymergen from an April 2013 startup to an 800-employee company with a $525 million 2021 IPO before it imploded a year ago.

Yahoo | August 26, 2022

Zymergen chief scientific officer to depart as company lays off more employees

  • Zach Serber, chief scientific officer of Zymergen (NASDAQ:ZY) and a co-founder, is leaving the company on Sept. 22.
  • Zymergen (ZY) also said it is laying off another 80 employees. This follows the termination of 80 employees in late July.
  • The company's shares are down 63% year to date.
  • Seeking Alpha's Quant ...

    Seeking Alpha | August 25, 2022

Ginkgo Bioworks Lifts Guidance After Mixed Q2 Results; Shares Surge

By Yasin Ebrahim

Yahoo | August 15, 2022

Why Biotech Disruptor Ginkgo Bioworks Is Well-Positioned for the Future

Beaten down from its highs late last year, cell engineering company Ginkgo Bioworks now looks primed to divide and conquer.

Yahoo | August 5, 2022

Read More 'ZY' Stories Here

ZY Price Returns

1-mo 18.14%
3-mo 133.33%
6-mo -3.11%
1-year -78.74%
3-year N/A
5-year N/A
YTD -58.15%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.5613 seconds.